Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects

Miguel Genebat, Francisco Vera, José Hernández-Quero, Pere Domingo, José M. Guardiola, Onofre Martínez-Madrid, Lorena Martínez, Francisco García De La Llana, Jorge Sánchez-Villegas, Hortensia Álvarez, Ana Mariño, José F. Lluch, María A. Martínez-Pérez, Jorge Marín, Ezequiel Ruiz-Mateos, Manuel Leal

    Research output: Contribution to journalArticleResearchpeer-review

    6 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects'. Together they form a unique fingerprint.

    Medicine & Life Sciences